*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">

In 2026, hospitals and health systems face a pivotal moment. Rapid advances in technology, rising consumer expectations, shifting payer dynamics and policy reforms are reshaping the economics of healthcare. Success will no longer hinge on incremental improvements but on the strategic ability to rethink care delivery, workforce management, community engagement, technology adoption and operational resiliency.

The following seven trends highlight critical areas where strategic focus and bold thinking have significant potential to shape the next era of value-driven care.

Trend 1: Taming the AI Wild West

By late 2025, 71 percent of U.S. hospitals had integrated some form of AI into daily operations, up from 66 percent in 2023. However, most (80 percent) still lack internal governance standards guiding future adoption. Furthermore, few have introduced processes that hardwire AI into workflows to drive meaningful improvement and long-term value. Without these fundamentals, health systems risk a patchwork of siloed tools rather than an integrated AI strategy.

Rather than adopting AI because it is novel or hyped, health systems should tame the AI "wild west" by combining a use-case approach with rigorous governance, pushing AI adoption beyond experimentation to become a strategic lever.

For 2026, four AI use cases are emerging as core areas of focus for the healthcare industry:

• Digital assistants will increasingly manage early care touchpoints, triaging symptoms, routing patients to the right care setting and smoothing scheduling to reduce unnecessary utilization.
• AI-enabled stewardship tools will flag low-value interventions and surface cost-efficient alternatives, reducing spend by about$100 per inpatient admission with no loss in quality.
• Predictive analytics will optimize staffing by forecasting demand, aligning skills with shifts and reducing burnout while containing labor costs.
• With hospitals managing 1,200-pluspurchasing contracts and 40,000 new line items every six months, AI will function as a "digital employee," activating contracts, interpreting pricing tiers and automating distribution tasks.

Trend 2: Think Local, Win Big: Partnering with Public Health

When COVID-19 hit, local health departments (LHDs) became indispensable partners, running testing, tracing and community engagement as hospitals managed the clinical surge. But those partnerships faded quickly: Today, only about half of health systems work with LHDs in any regular or strategic way.

But these barriers are rapidly dissolving. Technology now enables upstream engagement; value-based models (e.g., ACO REACH, Medicare Advantage) reward complication avoidance; and consumer platforms plus FHIR-based APIs make data sharing seamless. These shifts, in turn, make the ROI of community partnerships quantifiable, driving reductions in unnecessary utilization and readmissions.

To capitalize in 2026, healthcare leaders should evaluate where partnerships with LHDs could extend market presence and enhance performance in risk-based contracts. This means treating LHDs as extensions of core operations, aligning clinical services with social supports to ensure more proactive, community-integrated population health management.

Health systems should also inventory community-facing services to identify overlap and prevent duplication. Once identified, leaders can explore opportunities for consolidation, co-investment or shared service models to improve impact and financial sustainability.

To enhance data sharing, systems can:

• Integrate community health data into enterprise dashboards.
• Invite LHD leaders into joint planning and policy forums.
• Invest in shared data platforms, workforce pipelines and joint advocacy efforts that strengthen public health and prevent external shocks.

Trend 3: The Consumer Imperative: Competing on Value, Trust, Innovation and Access

Today's consumer is looking for high-quality services that conveniently deliver health and wellness at a transparent price point. They also want to avoid scheduling delays, impersonal service, cultural incompetence, and clunky and surprise billing.

To attract patronage (and premium dollars) in 2026, health systems must now prove they can deliver the best value, trust, innovation and access, all while maintaining the clinical excellence that remains their core differentiator. In this era, the traditional retail model of "customer care" needs to intersect with how systems deliver patient care.

Leading brands such as University Hospitals, AdventHealth and Ascension are embracing this imperative with easy-to-use pricing tools that allow patients to estimate their costs for medical services in advance and online. Others have redesigned billing statements to break down what the patient owes, what was covered by insurance and a detailed explanation of services provided.

Hospitals can also build trust by publicly sharing outcome metrics, patient satisfaction scores and accreditation achievements openly in easy-to-digest dashboards that facilitate comparisons. Similarly, health systems that aggressively report on their innovation strategies can establish leadership in high-reimbursement specialties, attract patients willing to pay for superior expertise and build community credibility.

But transparency alone is not enough. Competitiveness now requires a modern, frictionless delivery model built on a three-tier network: AI-first triage to direct patients quickly; telemedicine as the flexible connective layer; and physical sites as high-value anchors for multidisciplinary care.

This omnichannel structure expands reach, strengthens loyalty and positions organizations for long-term growth.

Trend 4: Doing Less, Winning More: Rationalizing Service Lines

Hospitals often try to be "everything for everyone," but low-volume or non-differentiated services drain capital, staff and focus. Particularly in a year where health systems must prepare for reimbursement cuts imposed by the One Big Beautiful Bill Act (OBBBA), 2026 is shaping up to be the time when C-suite leaders rationalize service lines and double down on areas of excellence.

Beyond financial benefits, a focused portfolio sharpens strategy, strengthens brand identity and aligns with how consumers choose care - by quality and outcomes, not breadth of services.

Despite the benefits of a service line focus, it is a goal that is easier to articulate than implement. Leaders may encounter:

• Cultural resistance from clinicians worried about access, reputation or competition. To combat this, leaders must emphasize that the goal is not to eliminate care but build true clinical excellence and high-value impact.
• Interdependencies across services that must be managed to avoid unintended consequences. Leaders should map all interdependencies and analyze pathways from admission through post-discharge follow-up.
• Regulatory and community obligations. To navigate, leaders should engage regulatory, legal and compliance teams early in the planning process to ensure that service consolidations do not violate contractual or licensure obligations.
• Data constraints that obscure true performance. To address these limitations, leaders should obtain consolidated data using analytics platforms or data partners that enable predictive modeling and scenario analysis.

Trend 5: Pills, Policy and Pressure: The Pharmaceutical Supply Chain Shake-Up

Pharmacy has become one of the most strategically consequential domains in healthcare. And in 2026, health system leaders must either get ahead of the change or pay for being reactive.

Clinically, drug shortages remain pervasive and are often worsened by fragmented procurement systems that increase waste and the potential for stockouts. The lack of diverse sources of pharmaceuticals, including onshore and nearshore options, creates additional volatility and heightened risk.

In 2026, the most resilient health systems will take a multi-pronged approach to better manage the pharmacy supply chain, pulling on three principal levers:

• Use of pharmacy compounding options to help ensure critical drugs are available for patient care while preserving quality and safety standards.
• Commitment-based shortage programs for priority access to medications based on clinical need and committed purchasing.
• Data-driven analytics and integrated supply chain management for real-time inventory tracking, predictive modeling and proactive stock management.

Outside of shortages, high-cost drugs in oncology, immunotherapy and rare disease care continue to outpace inflation and payer reimbursement growth. The threat of tariffs, policy changes to the 340B Drug Pricing Program, aggressive payer utilization management and pharmacy benefit managers (PBMs) further strain budgets, with many hospitals absorbing unreimbursed drug costs or losing preferred pricing due to shifting eligibility standards.

To address these pressures, health system leaders should renegotiate commercial contracts and explore risk-sharing or outcomes-based arrangements with manufacturers for high-cost specialty agents. They should also align incentives to protect profitability while maintaining patient access.

Centralizing procurement across outpatient clinics and hospitals, coupled with GPO contracts, is also a key to gaining purchasing leverage and reducing cost variability. Coordinated inventory management across sites, for instance, can mitigate stock-outs and ensure maximum utilization of 340B-eligible medications.

Trend 6: Pick, Partner, Prosper: Strategic Payer Moves for Margin and Growth

In 2026, health systems face a critical inflection point in payer strategy.

Medicare Advantage (MA) now covers 54 percent of eligible beneficiaries, which means that in most markets, heavy competition gives providers more control. Strategy-minded systems will capitalize, moving from a "cover-all-bases" approach to cherry-picking MA partners that protect financial performance, align with clinical strengths and enable scale.

To do this effectively, strategic systems are building payer scorecards that track financial yield, administrative friction and downstream quality performance to inform contracting decisions. Others are forming collaborative partnerships based on jointly designed care pathways, shared risk and aligned incentives that replace transactional relationships with strategic ones. In some markets, systems are even creating preferred payer networks with select MA plans that share a commitment to quality, access and transparency.

Similarly, Medicaid programs are shifting under the OBBBA, with reduced state support, new working requirements and higher cost sharing.

To offset these hits, leading systems are leveraging advanced analytics to identify the highest-need, highest-cost Medicaid patients and coordinating care with community partners and targeted interventions. At the same time, health systems should evaluate opportunities to participate in state-directed payment programs, value-based arrangements or supplemental funding pools that reward quality and access improvements. Operationally, hospitals should also invest in integrated data platforms to model the impact of OBBBA and better manage reimbursement and compliance.

Trend 7: Align, Analyze, Amplify: Smarter Management of Physician Networks

Building comprehensive physician networks began to capture referrals and coordinate care but has become a high-cost contributor to operating losses.

Owned medical groups saw 6 percent volume growth over 18 months, but new patient growth declined 6 percent, with access bottlenecks exceeding 30 days across specialties and 40-plus days in primary care. Meanwhile, physician compensation rose 8 percent faster than volumes, driving a 13 percent decline in margin per provider.

These twin challenges prove that traditional physician incentives based on work relative value units (RVUs) are often misaligned with health system strategic priorities of access and growth.

To enhance owned medical group performance, health systems in 2026 must invest in data tools that enable granular analysis of access, service-line performance, patient outcomes, payer mix and revenue streams. Advanced predictive modeling can forecast the financial impact of care redesign, site-of-service shifts or staffing changes before they are implemented, allowing leaders to act proactively.

Benchmarking analytics similarly enable leaders to identify variation in cost, utilization and outcomes. These insights inform incentive redesign, targeted interventions and operational changes that directly support margin improvement. Additionally, dashboards that provide near-real-time visibility into key performance indicators enable continuous monitoring and timely course correction.

Finally, integrating patient experience and quality data alongside financial metrics ensures that margin optimization does not come at the expense of outcomes or satisfaction.

What's Next: From Insight to Action

2026 is a year that will demand reinvention. To compete, health systems must re-engineer how they operate, redesigning service lines, payer relationships, workforce models, community engagement and supply chain infrastructure with the same rigor they apply to clinical care.

This level of transformation can feel daunting, but it is also a moment of opportunity. Health systems that act now will not simply weather disruption; they will define the next standard of value in American healthcare.

As 2026 unfolds, success will belong to the organizations that act with speed, precision and purpose. The time for incremental change has passed. The call to action is now.

Premier's 2026 market trends report explores the drivers shaping healthcare's next horizon, offering insights and actionable strategies. Ready to build adaptive, data-driven systems that combat volatility while putting consumers first? Download your copy today.